FGF1 and metabolic dysfunction-associated steatotic liver disease: The complex context of MASLD, which is characterized by insulin resistance, lipotoxicity and oxidative as well as ER stress may explain why some but not all of the pathways that can potentially be modulated by mTORC and the UPR, are acutely activated by FGF1.49